We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.34%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$55.7B
AUM Growth
-$11.4B
Cap. Flow
-$9.72B
Cap. Flow %
-17.45%
Top 10 Hldgs %
9.49%
Holding
4,137
New
382
Increased
1,324
Reduced
1,495
Closed
773

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$397M
2
YHOO
Yahoo Inc
YHOO
+$342M
3
BAC icon
Bank of America
BAC
+$322M
4
C icon
Citigroup
C
+$260M
5
BKNG icon
Booking.com
BKNG
+$219M

Sector Composition

Rank Sector Weight
1 Healthcare 13.78%
2 Technology 11.11%
3 Financials 10%
4 Consumer Discretionary 8.83%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAH icon
3401
PUT
Cardinal Health
CAH
$54B
-110,000
Closed -$9.82M
CAR icon
3402
CALL
Avis
CAR
$5.19B
-141,700
Closed -$5.14M
CBT icon
3403
Cabot Corp
CBT
$4.33B
-16,695
Closed -$682K
CC icon
3404
Chemours
CC
$2.32B
-1,443,435
Closed -$7.74M
CC icon
3405
PUT
Chemours
CC
$2.32B
-14,880
Closed -$80K
CCEP icon
3406
PUT
Coca-Cola Europacific Partners
CCEP
$48.6B
-2,050,000
Closed -$101M
CCI icon
3407
CALL
Crown Castle
CCI
$32.5B
-10,000
Closed -$865K
CCI icon
3408
PUT
Crown Castle
CCI
$32.5B
-10,000
Closed -$865K
CCJ icon
3409
PUT
Cameco
CCJ
$44.5B
-70,000
Closed -$863K
CCL icon
3410
PUT
Carnival Corporation Ltd
CCL
$35.2B
-5,000
Closed -$272K
CCOI icon
3411
Cogent Communications
CCOI
$486M
-707,527
Closed -$24.5M
CCRN
3412
DELISTED
Cross Country Healthcare
CCRN
-14,442
Closed -$237K
CDE icon
3413
PUT
Coeur Mining
CDE
$21.5B
-50,000
Closed -$124K
CHDN icon
3414
PUT
Churchill Downs
CHDN
$6.32B
-60,000
Closed -$1.42M
CHKP icon
3415
CALL
Check Point Software Technologies
CHKP
$13.3B
-34,700
Closed -$2.82M
CHKP icon
3416
PUT
Check Point Software Technologies
CHKP
$13.3B
-20,000
Closed -$1.63M
CHRD icon
3417
CALL
Chord Energy
CHRD
$7.91B
-20,000
Closed -$147K
CHRW icon
3418
CALL
C.H. Robinson
CHRW
$16.7B
-20,000
Closed -$1.24M
CHRW icon
3419
PUT
C.H. Robinson
CHRW
$16.7B
-64,200
Closed -$3.98M
CIEN icon
3420
Ciena
CIEN
$52.7B
-25,970
Closed -$480K
CIEN icon
3421
PUT
Ciena
CIEN
$52.7B
-44,700
Closed -$925K
CL icon
3422
CALL
Colgate-Palmolive
CL
$73.8B
-69,800
Closed -$4.65M
CL icon
3423
PUT
Colgate-Palmolive
CL
$73.8B
-43,800
Closed -$2.92M
CLDX icon
3424
Celldex Therapeutics
CLDX
$3.19B
-6,281
Closed -$1.48M
CLX icon
3425
PUT
Clorox
CLX
$13B
-32,500
Closed -$4.12M

Similar funds

David Shaw's Q1 2016 Portfolio in Review

As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.

  • David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
  • David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
  • David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
  • David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
  • David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
  • David Shaw opened 382 new positions and closed 773 in Q1 2016.
  • David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.